< Zurück zu den aktuellen Neuigkeiten & Events

Artikel

Made in China

April 2020

SPC’s position on OEM – Honda case. Although China is becoming an increasingly important consumer market, it still has the reputation of being a cheap (counterfeit) production country, with “Original Equipment Manufacturers” (OEM) being the motor of the Chinese economy.

Made in China 2025

With its Government campaign “Made in China 2025”, China is now trying to lose its image of (counterfeit) ‘factory of the world’ and aims to put its own trademarks in the spotlights.

Counterfeit production by OEM

OEM simply means that a manufacturer is commissioned to manufacture products and attach the commissioner’s trade mark to same. Often these products do not enter the Chinese marketplace and are exported abroad.

Obviously, China’s OEM have been and are being used by honest trade mark owners around the world. They, however, also play an important role in the production of counterfeit goods.

Stopping counterfeit production is a difficult task. Although a registered (foreign) trade mark is required in order to be able to commission OEM, it is not the OEM’s job to assess whether such trade mark is obtained in good faith. As such, bad faith registrations (either Chinese or foreign) form a basis for justifying counterfeit production. On top of that, the Supreme Court ruled that OEM use “should not be regarded to infringe the legitimate rights of the owner of a Chinese trade mark, when such goods are not made available in the Chinese marketplace, but exported to other countries”. In other words: use by OEM was not considered to infringe Chinese trade marks.

It, however, now looks as if things are going to change because of the “Made in China 2025” campaign – China is finally prepared to battle bad faith and counterfeit.

Amended Trademark Laws

1st November 2019, the Trade Mark Law has been amended. Important amendments include that:

  • Bad faith filings without a genuine intention to use shall be rejected
  • Bad faith can serve as basis for opposition/revocation
  • It is illegal for trade mark agencies to represent bad faith filers
  • There are increased filing fees and penalties/compensation to put off bad faith filers
  • There are penalties for ‘bad faith trade mark infringement claims’

Blocking bad faith filers will be of enormous assistance in fighting counterfeit production.

Honda  (Honda Motor Co., Ltd v  Chongqing Hengsheng Xintain Trading Co., Ltd et Chongqing Hengsheng Group Co., Ltd [Min Gao Fa Zai No. 138/2019]

In the important HONDA case of September 2019, the Supreme Court (“SPC”) decided that OEM should no longer be seen as an exception to trade mark infringement.

Background

Honda owns a Chinese trade mark HONDA for vehicles in class 12. A Chinese OEM manufactured vehicle parts commissioned by a company who owned a Myanmar trade mark HONDAkit. On the vehicle parts, the wording HONDA was prominently displayed. All goods were exported out of China. Honda brought a trade mark infringement lawsuit against the Chinese OEM, who justified production on the basis of the Myanmar trade mark and the fact that OEM does not constitute trade mark use. Honda won at first instance but lost on appeal, subsequently applying to the SPC for a retrial.

Decision

The SPC decided that – contrary to previous decisions – the OEM defence was not sufficient: a foreign trade mark (in this case, Myanmar) should not be able to serve as defence against a trade mark infringement claim based on a valid Chinese trade mark.

It concluded that it is not necessary to make the goods available to Chinese consumers (end users) to ascertain use of the trade mark, as the relevant public can also consist of third parties labelling, transporting and distributing the trade marked products, such as distributors and transportation companies. In addition it mentioned that Chinese consumers could also encounter these products when traveling abroad.

Good news

The decision stretches the concept of the relevant public and trade mark use. This, however, is in favour of legitimate trade mark owners who can now tackle counterfeit production on the basis of their Chinese trade marks.

There is also another advantage OEM use will likely now be more sufficient to meet the Chinese use requirements (provided that sufficient evidence is collated). That means that even if you do not sell your products in China, your Chinese trade mark will not become vulnerable to non-use actions, and could even assist in tackling counterfeit production as mentioned above.

Risks

However, there are also risks involved. If you are currently producing in China without having a registered Chinese trade mark in place, OEM may potentially require you to obtain such registration, which could be difficult. Not having a Chinese trade mark in place includes a risk that an owner of an identical/similar Chinese trade mark could claim that your OEM use infringes their trade mark.

What to take away
  • Take active action to combat bad-faith trademarks
  • Collate sufficient evidence of your own OEM use to be able to prove genuine use of your trade mark in China (in the form of license agreements, purchase orders, delivery notes, customs declarations and dated product photos)
  • Act first and do not wait to register your trade mark if you intend to use or produce in China.

Aktuelle Neuigkeiten

WIPR Leaders 2026

We are proud to announce that five of our attorneys have been recognised in the 2026 WIPR Leaders directory, a prestigious guide to the world’s leading intellectual property practitioners. Pieter …

Weiterlesen

Celebrating Our New Partners

We are delighted to announce that, with effect from 1 May, HGF has promoted five colleagues to Partner. This important milestone recognises not only their individual achievements and leadership, but …

Weiterlesen
Event - 11. bis 12. Mai 2026

HGF ist stolz darauf, am 14th Microbiome R&D and Business Collaboration Forum: Europe sowie am 8th Skin Microbiome and Cosmeceuticals Congress: Europe teilzunehmen.

HGF ist stolz darauf, am 14th Microbiome R&D and Business Collaboration Forum: Europe sowie am 8th Skin Microbiome and Cosmeceuticals Congress: Europe teilzunehmen. Die Veranstaltung findet am Montag, den 11., …

Veranstaltungsdetails
Event - 27. April 2026

HGF are proud to be Gold Sponsors of IP Counsel Café

HGF are proud to be Gold Sponsors of IP Counsel Café on 12-14th May at Silicon Valley, US. HGF Partner Susan Keston will be speaking at on the topic AI …

Veranstaltungsdetails

Seven HGF Attorneys Recognised in the 2026 Pro Bono Recognition List

We’re proud to share that seven of our attorneys have been named on the 2026 Pro Bono Recognition List of England & Wales, recognising those who have dedicated 25 hours …

Weiterlesen

PRESSEMITTEILUNG Oliver Pooley tritt am 21. April 2026 als Partner bei HGF ein.

HGF freut sich, die Ernennung von Oliver Pooley bekannt zu geben, der dem Unternehmen am 21. April 2026 als Partner beitreten wird. Oliver verstärkt die Technology & Engineering Group von …

Weiterlesen
Event - 16. April 2026

MedTech Innovation Summit 2026

Adam Hines, Partner bei HGF und Patentanwalt, wird am MedTech Innovation Summit Dublin 2026 teilnehmen, der vom 28. bis 30. April im The Shelbourne Hotel stattfindet. Als eine der führenden …

Veranstaltungsdetails
Event - 2. bis 6. Mai 2026

INTA-Jahrestagung 2026

Das europäische Team von HGF freut sich, an der INTA-Jahrestagung 2026 teilzunehmen, die vom 2. bis 6. Mai in London stattfindet. Als eine der führenden IP-Kanzleien Europas vereint HGF Anwältinnen …

Veranstaltungsdetails